LDs-BCA
LDs-BCA is a BF2-chelated AIE fluorescent probe with a positive solvatochromic effect, which can specifically target intracellular lipid droplets (Ex/Em = 565/620-730 nm). LDs-BCA monitors the dynamic changes in the morphology, size and quantity of intracellular lipid droplets under oleic acid induction and starvation stress. LDs-BCA, after intraperitoneal injection, accumulates in the gastric fat of living obese mice, allowing continuous monitoring via its fluorescent signal. LDs-BCA is applicable to studies related to intracellular lipid droplet polarity imaging and in vivo gastric fat visualization.
For research use only. We do not sell to patients.
- CAS No.: 3077446-86-4
- Formula: C34H29BF2N2O4
- Molecular Weight:578.41
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
In Vitro
Guidelines (The recommended experimental protocol below is for guidance only and should be modified according to your specific requirements)
1. Stock Solution Preparation
1.1 Solvent: Ultrapure water containing 1% DMSO.
1.2 Concentration Recommendation: Prepare a high-concentration stock solution with a concentration of 1-10 mM.
2. Working Solution Preparation
2.1 Diluent: Serum-free medium or PBS is commonly used. Proteins and esterases in serum may interfere with staining results or cause dye hydrolysis.
2.2 Working Concentration: 10 μM.
2.3 Notes: Adjust the working solution concentration as needed; prepare and use it immediately.
3. Staining Procedures
3.1 Adherent Cell Assay[1]:
3.1.1 Sample Types: A549 cells, HeLa cells.
3.1.2 Incubation Conditions: Incubate with 10 μM LDs-BCA for 10 min.
3.2 In Vivo Mouse Gastric Tissue Assay[2][3]:
3.2.1 Sample Types: Gastric tissues of normal and obese live mice.
3.2.2 Incubation Conditions: Incubate with LDs-BCA; the observable duration of fluorescence signal reaches up to 12 h; monitor lipid droplet metabolism in gastric tissues.
3.3 In Vivo Live Mouse Assay[1]:
3.3.1 Sample Types: Obese and normal live mice.
3.3.2 Incubation Conditions: Intraperitoneally inject 100 μL of 1 mM LDs-BCA; perform imaging 10 min later.
4. Control Setup
4.1 Cell Assay Controls: Untreated HeLa cells, HeLa cells incubated with complete 1640 medium, untreated A549 cells.
4.2 In Vivo Mouse Assay Controls: Normal mice injected with 1 mM LDs-BCA, obese mice without probe injection, gastric tissues of normal mice (negative control), gastric tissues of obese mice (positive control).
4.3 System Validation Controls: Positive control (for validating the experimental system); blank control (for eliminating reagent fluorescence interference).
5. Detection and Analysis
5.1 Instrument Types: Laser confocal scanning microscope; fluorescence imaging system.
5.2 Excitation/Emission Wavelengths:
5.2.1 Cell Imaging: Ex = 565 nm, Em = 620-730 nm.
5.2.2 In Vivo Imaging: Ex = 560 nm, Em = 670 nm; Ex = 570 nm, Em = 650 nm.
5.3 Result Analysis:
5.3.1 Fluorescence Intensity Evaluation: The fluorescence intensity in the gastric region of obese mice is significantly higher than that of normal mice; the fluorescence intensity of HeLa cells treated with oleic acid or HBSS is stronger than that of control cells; strong fluorescence signals are observable in gastric tissues of obese mice, while signals in gastric tissues of normal mice are negligible.
5.3.2 Fluorescence Localization: Red fluorescence specifically localizes to intracellular lipid droplets (with a high overlap coefficient with commercial lipid droplet dyes); in in vivo assays, red fluorescence targets gastric fat in obese mice.
5.3.3 Dynamic Monitoring: Track changes in the gastric fat microenvironment; monitor the dynamics of lipid droplet metabolism.
5.3.4 Fluorescence Color: LDs-BCA emits red fluorescence in lipid droplets and gastric fat.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
In Vivo
LDs-BCA (100 μL 1 mM; i.p.; single administration) exhibits extremely low non-specific fluorescence in the gastric region of living normal mice[1].
LDs-BCA (100 μL, 0.5-2 mM; intraperitoneal injection; single administration) shows no significant in vivo toxicity in mice at high doses[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Obese mice (weight >120% of control normal mice; high-fat diet-induced obesity)[1]
-
Dosage:100 μL 1 mM
-
Administration:i.p.; single dose
-
Result:Showed significantly higher fluorescence intensity in the gastric area compared to normal mice at 10 minutes post-injection.
Displayed gradually increasing gastric fluorescence signal within 3 hours post-injection, which remained above background up to 12 hours.
Exhibited ~32-fold higher fluorescence intensity in dissected stomachs than normal mouse stomachs 12 hours post-injection.
Showed minimal fluorescence intensity differences in other organs compared to normal mice.
-
Animal Model:Normal mice[1]
-
Dosage:100 μL 1 mM
-
Administration:i.p.; single dose
-
Result:Showed low fluorescence intensity in the gastric area at 10 minutes post-injection.
Displayed minimal fluorescence signal in dissected stomachs 12 hours post-injection.
-
Animal Model:Normal mice[1]
-
Dosage:100 μL 0.5 mM; 100 μL 1 mM; 100 μL 2 mM
-
Administration:i.p.; single dose
-
Result:Achieved 100% survival over 15 days post-injection, with normal appearance, mental state, behavior, and body weight gain.
Showed no obvious structural abnormalities or inflammatory cell infiltration in heart, kidney, liver, lung, and gastric tissues 7 days post-injection of the highest dose (100 μL 2 mM).
Chemical Information
-
CAS No. 3077446-86-4
-
Molecular Weight 578.41
-
Formula C34H29BF2N2O4
-
SMILES
CCN(CC)C1=CC(O2)=C(C=C1)C3=O[B+3]([F-])([F-])O=C([C-]3C2=O)/C=C/C(C=C4)=CC=C4N(C5=CC=CC=C5)C6=CC=CC=C6
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)